SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001385508-22-000134
Filing Date
2022-11-15
Accepted
2022-11-14 17:37:37
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A opiantdefa14a11-1413731855.htm DEFA14A 72023
2 image_0a.jpg GRAPHIC 14087
3 image_1a.jpg GRAPHIC 90986
4 image_2a.jpg GRAPHIC 10092
5 image_3a.jpg GRAPHIC 169791
  Complete submission text file 0001385508-22-000134.txt   466155
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38193 | Film No.: 221388162
SIC: 2834 Pharmaceutical Preparations